Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors Report - Competitive Landscape, Market and Pipeline Analysis 2017 - Research and Markets

Research and Markets
Posted on: 24 Aug 17

The "Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors - Competitive Landscape, Market and Pipeline Analysis 2017" drug pipelines has been added to Research and Markets' offering.

Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors - Competitive Landscape, Market and Pipeline Analysis 2017 provides comprehensive insights about pipeline drugs across Cyclin Dependent Kinase 4/6 inhibitors. A key objective of the report is to establish the understanding for the therapeutic competitive landscape for this mechanism of action. It provides the marketed product details in this area.

It also covers the pipeline drugs that fall under Cyclin Dependent Kinase 4/6 inhibitors including their comparative analysis at various stages covering Filed, Phase II, Phase I, Pre-clinical, and inactive products, therapeutics assessment by monotherapy and combination products and molecule type. The report also provides the market drivers and barriers for CDK 4/6 inhibitors.

Key Topics Covered:

  1. Executive Summary
  2. Overview
  3. Marketed Drugs
  4. Pipeline Therapeutics
  5. Last Stage Products (Phase III)
  6. Mid Stage Products (Phase II)
  7. Early Stage Products (Phase I)
  8. Pre-clinical Stage Products
  9. Therapeutic Assessment: Active Products
  10. Inactive Products
  11. Market Drivers and Barriers
  12. Appendix

Companies Mentioned

  • Astex
  • BetaPharma
  • Eli Lilly
  • FLXBIO
  • G1 Therapeutics
  • Jiangsu HengRui Medicine
  • MetaMax
  • Novartis
  • Onconova
  • Pfizer
  • Presage Biosciences
  • Sumitomo Dainippon Pharma
  • Tragara
  • Triziana Life Sciences
  • ViroStatics

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/d9bf55/cyclin_dependent

View source version on businesswire.com: http://www.businesswire.com/news/home/20170824006040/en/

Business Wire
www.businesswire.com

Last updated on: 24/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.